General Information of DTT (ID: TT51DEV)

DTT Name Interleukin 1 receptor type 2 (IL1R2) DTT Info
Gene Name IL1R2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Clinical Trial Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK-1827771 DMA41JD Rheumatoid arthritis FA20 Phase 1 [1]
------------------------------------------------------------------------------------
3 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AMG 108 DMMUS8X Rheumatoid arthritis FA20 Discontinued in Phase 2 [2]
FR-133605 DMXWL0N Arthritis FA20 Terminated [3]
MRL-953 DM4A92X Immune System disease 4A01-4B41 Terminated [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 WO patent application no. 2013,0077,63, Modulators of the nlrp3 inflammasome il-1ss pathway for the prevention and treatment of acne.
2 Clinical pipeline report, company report or official report of Amgen (2009).
3 Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats. J Rheumatol. 1996 Oct;23(10):1778-83.
4 SDZ MRL 953, a lipid A analog as selective cytokine inducer. Prog Clin Biol Res. 1995;392:549-65.